Clinical Evaluation of Ceramage Inlays Cemented With Beautilink Self-Adhesive Resin Cement Versus… (NCT06833177) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Clinical Evaluation of Ceramage Inlays Cemented With Beautilink Self-Adhesive Resin Cement Versus Rely X Resin Cement in Carious Posterior Teeth
Egypt50 participantsStarted 2025-11-11
Plain-language summary
Minimally invasive bonded partial restorations have become a crucial component of contemporary dental treatments. They address the shortcomings of direct restorations and provide patients with a less damaging alternative to full coverage restorations, which can be more harmful to the dental structure. Indirect inlay composite restorations have become a popular choice in restorative dentistry due to their aesthetic appeal and durability. These restorations allow for the preservation of tooth structure while utilizing the mechanical advantages of modern adhesive technology, which can reinforce the weakened compromised tooth structure.
The use of different adhesive materials with Ceramage can significantly influence the success of the restoration. Adhesive materials play a crucial role in ensuring a strong bond between the indirect restoration and the tooth structure. Additionally, the choice of adhesive material can also affect the ease of the cementation process. Self-adhesive resin cement simplifies the procedure by eliminating the need for separate bonding agents, thus reducing the risk of technique sensitivity which can lead to more consistent clinical outcomes and improved patient satisfaction.
Overall, the combination of Ceramage with appropriate adhesive materials offers a reliable and aesthetically pleasing solution for indirect inlay composite restorations, enhancing both the biological, functional and esthetic outcomes of dental treatments.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Posterior vital tooth with a large carious lesion (ICDAS 4/5)
* Posterior vital tooth with a broken restoration that should be replaced (ICDAS 4-7/5-7).
* Vital, periodontally sound and with positive reaction to cold stimulus.
* Fully erupted posterior molar in normal functional occlusion with natural antagonist and adjacent teeth.
Exclusion Criteria:
* Teeth with clinical symptoms of pulpitis such as spontaneous pain or sensitivity to pressure.
* Non-vital teeth, Fractured or cracked teeth.
* Endodontically treated teeth.
* Periodontally affected teeth.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is comparing two different resin cements used to bond ceramic inlays in teeth with cavities — can you explain how these two cements, Beautilink and RelyX, differ from each other, and whether either one is already considered a standard option for my situation?
2Since this trial is actively running but no longer enrolling new participants, does that mean I've missed the chance to be part of it, and are there similar studies I could still join that are testing ceramic inlay cements?
3The trial measures how well the inlays perform biologically, mechanically, and aesthetically using something called Modified USPHS Criteria — what does that actually mean in practical terms, and how would any problems with the inlay show up during my follow-up visits?
4A ceramic inlay is one approach to restoring a Class II cavity, but are there other restorations like direct composite fillings or crowns that might be a better fit for my specific tooth damage before considering something more experimental?
5Because this trial is in the 'NA' phase, what does that tell us about how well-established the safety and long-term performance of these two cements are, and should that affect my confidence in choosing one over the other?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Clinical Performance assessing Biological, Mechanical and Esthetic Parameters Using Modified USPHS Criteria